J&J to acquire maker of 3D-printed spinal implants

Johnson & Johnson (J&J) announced this week that its subsidiary  J&J Medical has acquired Emerging Implant Technologies ( EIT) for an undisclosed amount.

The acquisition of the Germany-based company was announced on Wednesday, September 12 and will see J&J leverage EIT’s technologies to reach patients on an international level.

EIT manufactures 3D-printed titanium interbody implants for spinal fusion surgery.

The deal will allow J&J to strengthen its orthopaedic interbody implant portfolio—managed by J&J’s subsidiary DePuy Synthes.

“Our goal is to offer a complete portfolio of interbody solutions that provides surgeons with even more options for the treatment of their patient,” commented Aldo Denti, chairman of DePuy Synthes.

Denti added: “We are excited to welcome the skilled team at EIT, and together, we aspire to bring to market technologies that allow surgeons to perform spinal fusion reliably and with consistent outcomes.”

J&J said that DePuy Synthes will continue to focus on solutions to degenerative disc disease, deformity and complex cervical diseases.

In March 2018, J&J revealed plans to sell its blood glucose monitoring unit, LifeScan, for $2.1 billion.

Last year, J&J announced that another of its subsidiaries, Johnson & Johnson Services, has begun a research collaboration with 3D printing startup Inkbit Corporation.

Did you enjoy reading this story?  Sign up to our free daily newsletters and get stories sent like this straight to your inbox.